Opana ER (Oxymorphone)-Induced Thrombotic Microangiopathy: An Atypical Presentation in a Patient With Hepatitis C

• Main Authors: Hassan Mehmood MD (Author), Muzammil Khan MD (Author), Asghar Marwat MD (Author), Medha Joshi MD (Author), Varun Malhotra MD (Author)
• 格式: 圖書
• 出版: SAGE Publishing, 2018-01-01T00:00:00Z.
• 主題: article
• 在線閱讀: Connect to this object online.

Oxymorphone is a semisynthetic extended release opiate used to treat moderate to severe chronic pain. The Food and Drug Administration approved the oral form of oxymorphone available as Opana and Opana ER (extended release) since 2006. The Food and Drug Administration and the Centers for Disease Con...